Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: COVID-19 | Health Management